rusfertide
protagonist therapeutics
['mpnsm', '#mpn', 'rusfertide']
#eha2023 | presents withdrawal results of the revive study of rusfertide in pcv in the 1st lba. n=53. response rate =69.2% for rusfertide vs 18.5% for placebo (p=0.0003). 92.3% pts in the rusfertide cohort didn't received phlebotomy. #mpn #mpnsm 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm